The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Mol. Neurosci.
Sec. Brain Disease Mechanisms
Volume 17 - 2024 |
doi: 10.3389/fnmol.2024.1391040
Analysis of the pathogenicity and pathological characteristics of NOTCH3 gene-sparing cysteine mutations in vitro and in vivo models
Provisionally accepted- 1 Xinxiang Medical University, Xinxiang, China
- 2 Department of Neurology, Henan Provincial People’s Hospital, Zhengzhou, Henan Province, China
- 3 Zhengzhou University, Zhengzhou, Henan Province, China
- 4 Henan University, Kaifeng, Henan Province, China
- 5 Academy of Medical Sciences, Zhengzhou University, Zhengzhou, Henan Province, China
Background: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is one of the most common inherited cerebral small vessel diseases caused by the NOTCH3 gene mutation. This mutation leads to the accumulation of NOTCH3 extracellular domain protein (NOTCH3 ECD ) into the cerebral arterioles, causing recurrent stroke, white matter lesions, and cognitive impairment. With the development of gene sequencing technology, cysteine-sparing mutations can also cause CADASIL disease, however, the pathogenicity and pathogenic mechanisms of cysteine-sparing mutations remain controversial. Objective: To analyze the pathogenicity and pathological features of cysteine-sparing mutations in both in vitro and in vivo mouse models. Methods: A cysteine-sparing mutant of NOTCH3 ECD R75Q was constructed by lentiviral transfection in vitro, and the NOTCH3 R75Q knock-in mouse model was constructed by CRISPR/Cas-mediated genome engineering in vivo. A cycloheximide pulse-chase experiment was used to analyze the degradation of NOTCH3 extracellular domain proteins, and the deposition characteristics of NOTCH3 ECD were quantitatively analyzed by immunohistochemical staining. The characteristics of the smooth muscle cells and granular osmiophilic materials were observed using electron microscopy.We elucidated that the NOTCH3 R75Q mutation is pathogenic. NOTCH3 ECD R75Q was found to be resistant to protein degradation and more likely to cause abnormal aggregation of NOTCH3 ECD , resulting in reduced cell activity in vitro. The NOTCH3 R75Q mouse model showed pathological characteristics of CADASIL, with age-dependent NOTCH3 ECD , granular osmiophilic material , and degenerated smooth muscle cells detected in the brain.To our knowledge, this is the first study to analyze the pathogenicity of NOTCH3 R75Q cysteine-sparing mutations in both in vitro and in vivo models. We demonstrate that NOTCH3 ECD induced by NOTCH3 R75Q mutation has toxic effects on cells and reveal the deposition characteristics of NOTCH3 ECD in the brain. This provides a feasible model and lays the foundation for further studies on the pathogenesis and therapeutic strategies of NOTCH3 cysteine-sparing mutations.
Keywords: CADASIL, Cysteine-sparing NOTCH3 mutation, NOTCH3 ECD, in vitro cell model, in vivo Knock-in mice model
Received: 26 Feb 2024; Accepted: 29 Nov 2024.
Copyright: © 2024 Gong, Wang, Zhao, Wang, Lu, Sun, Zhang, Wang and Jiewen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Fengyu Wang, Department of Neurology, Henan Provincial People’s Hospital, Zhengzhou, 45003, Henan Province, China
Zhang Jiewen, Zhengzhou University, Zhengzhou, 450001, Henan Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.